Antibodies have become an established treatment modality in cancer therapy during the last decade.
Antibody-based therapy, including radioimmunotherapy, is one of the most important strategies for treating patients with lymphomas as well as solid tumors today (2) . Recently, tumor accumulation and heterogeneity of 111 In-Ibritumomab tiuxetan as well as 18 F-FDG was analyzed and compared to the radioimmunotherapy response in 16 patients with B-cell NHL (3) . It was found that the heterogeneity of intratumoral 111
In-Ibritumomab tiuxetan distribution, rather than the absolute level of antibody uptake, correlated with tumor response. Interestingly, no differences in heterogeneity were observed between responder and non-responder groups when using the small molecule metabolic radiotracer 18 F-FDG.
Such studies clearly show that therapeutic success is highly influenced by the intratumoral access of the therapeutic antibody reagent, a generally problematic feature of this class of high molecular weight proteins. Especially in radioimmunotherapy a non-uniform distribution within tumors appears to limit efficacy (4) . Therefore, attempts are made for searching diagnostic biomarkers to predict therapeutic outcome by using histopathology (5) or perfusion measurements (1).
To our knowledge there are no well characterized preclinical xenograft models showing mutually similar tumor biology and target expression in spite of profound differences in tumor perfusion. Hence, the goal of this study was to compare and investigate two exemplary NHL subtypes, the mantle cell lymphoma cell line Granta519 (6) and the diffuse large B-cell lymphoma cell line SUDHL-4 (7), which exhibit similar CD20 expression level, as subcutaneous human tumor xenograft models in immunocompromised mice using multimodal imaging methods. 
MATERIALS AND METHODS

Preparation and radioiodination of CD20 Fabs
The CD20-specific Fab, derived from Ofatumumab, was produced in E. coli in two versions, either fused with an albumin-binding domain (ABD) or with a long conformationally disordered amino acid sequence consisting of proline, alanine and serine (PAS) and labeled with 125 I using the Iodogen method as previously described (8) .
Radiosynthesis of
18
F-FDG
18
F-FDG was produced by the Radiopharmacy Unit, Technische Universität München, essentially as described before (9) . I-Fab-ABD as described before (8) . All animal experiments were in compliance with regulatory and institution guidelines and approved by the local authorities (Regierung von Oberbayern, Germany; licence 55.2-1-54-2532-87-11).
In vivo studies
SUDHL-4 and
Histology and Immunohistochemistry
Excised specimen were fixed in 4 % (w/v) neutrally buffered formalin, embedded in paraffin and cut into 3 µm slices. 
Light-Sheet Fluorescence microscopy (LSFM)
Fab-PAS 200 (2 mg/ml) was coupled at 5:1 molar ration with Cy5-NHS ester (Lumiprobe) in 0.1 M NaHCO 3 pH 8.5 for 2 h at room temperature. After removal of excess dye via PD-10 column in phosphate buffered saline, a labeling ratio of 1.6 fluorophores per Fab was determined via UV-VIS spectroscopy.
CB-17 SCID mice were intravenously injected with 0.7 nmol Cy5-labeled Fab-PAS 200 and, after 24 h, with 2 nmol Lectin from Bandeiraea (Griffonia) simplicifolia-Isolectin I (Sigma-Aldrich: L2380) labeled with VivoTag-S 750 (PerkinElmer) -for specific vessel visualization -followed by incubation for 5 min before the animals were sacrificed. Explanted xenografts were fixed in PaxGene (PreAnalytiX) as described (11) and then subjected to a chemical procedure of optical clearing (12).
Whole xenografts were imaged with a LaVision 3D ultramicroscope system (LaVision BioTec). The specimens were two-sided illuminated by a planar light-sheet using a white light laser (SuperK EXTREME EXW-9; NKT Photonics). Lectin and Cy5-Fab-PAS 200 were excited at 740/35 nm and 640/30 nm, respectively, while the emitting light was detected using 795/50 nm and 690/50 filters. Optical sections were recorded by moving the specimen chamber vertically (step size = 5µm) through the laser light-p. 7 Perfusion study of lymphoma xenografts sheet. 3D-reconstructions were obtained using ImspectorPro 5.0.1 Software (LaVision BioTec) and arivis Vision4D (arivis).
DCE-MRI Experiments
Mice were anesthetized and placed in prone position on top of a 47 mm microscopy surface coil in the 1. were identified and analysed using the Definiens Developer XD2 software (Definiens) as described (15) .
First, a specific rule set was defined to detect the CD31-stained vessel wall based on fluorescence-layer, intensity, shape and neighbourhood. Next, a distance map algorithm was applied to define distance ranges surrounding the vessels with stepwise increasing distance from 0-25 µm up to 175-200 µm.
Finally, the overall mean H33342 intensity was calculated for each vessels and distance range.
Statistics
For comparison between two groups, Student's t test for unpaired data was used. P values of <0.05 were considered statistically significant.
RESULTS
Characterization of SUDHL-4 and Granta lymphoma xenografts
The xenograft tumor morphologies of the two distinct NHL cell lines Granta519 and SUDHL-4 were investigated with regard to in vivo biodistribution and autoradiography in immunocompromised mice using the metabolic radiolabel 18 F-FDG as well as the radioiodinated CD20 tracers F-FDG autoradiography revealed a homogeneous distribution pattern in both xenografts, thus verifying metabolic activity and tumor viability (Fig. 1A) . Also, the two versions of the CD20-specific Fab, both engineered for extended plasma half-life using either PASylation technology or an ABD, showed strong, though heterogeneous distribution in Granta tumors 24 h p.i. (Fig. 1A) . In contrast, the SUDHL-4 xenograft exhibited an unusual rim of concentrated tracer signal with minimal radioactivity in the tumor lumen.
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These findings were confirmed by biodistribution experiments, which indicated strong tumor accumulation 24 h p.i. of 12.3 %ID/g and 2.4 %ID/g, respectively, for Fab-ABD and Fab-PAS 200 as well as high tumor-to-organ ratios in the Granta xenografts (Supplemental Table 1 ). However, drastically reduced tumor uptake, by 3.5-and 3.2-fold for Fab-ABD and Fab-PAS 200 , respectively, was observed for the SUDHL-4 tumors as also indicated by low tumor-to-organ ratios (Figs. 1B and 1C) . Nevertheless, similar tracer distribution in the organs was found for both models. In addition, no correlation between tracer uptake and tumor size, typically in the range of 100-800 mm 2 , was seen (Fig. 1D ).
For efficient tumor uptake and tracer distribution, the expression pattern of the target antigen CD20 is crucial. In agreement with previously published data, high CD20 expression of both lymphoma cell lines was verified using FACS analysis of the cell lines (data not shown) prior to tumor inoculation (16) . Also, ex vivo immunohistochemical staining of explanted tumors showed high CD20 expression with 100 % positive cells in all slides ( Fig. 2A ).
Apoptosis and proliferation are further factors that can influence tracer distribution and, thus, were here investigated ( Fig. 2A) . Immunohistochemical analysis of activated caspase 3 clearly revealed absence of large apoptotic areas, with less than 5 % positively stained cells for total caspase 3. Tumor viability was further confirmed by hematoxylin and eosin (H&E) staining of SUDHL-4 xenografts with a size of 800 mm 3 ( Fig. 2B) . Notably, according to the Mib1 marker a significantly higher proliferation rate was seen for the Granta xenografts (p = 0.01) (Fig. 2C) .
Finally, both xenografts showed a homogeneously distributed vasculature with CD31-stained vessels in the tumor center as well as in the periphery (Fig. 2A) . However, quantification of vessels revealed that vascularization was significantly higher, by a factor around two, in the Granta xenografts (Fig. 2D) .
by (Fig. 3A) . Lectin staining revealed well vascularization across the entire xenografts. Notably, in the Granta tumor a heterogeneous distribution of the fluorescently labeled Fab-PAS 200 was found, similar to the one observed with the radiolabeled Fab using autoradiography. In contrast, SUDHL-4 tumors showed a rim-like distribution pattern, again as seen before using autoradiography. When merging the images obtained for the Fab and the lectin, localization of the Fab only inside the tumor vessels was observed for the SUDHL-4 xenografts whereas the Fab was clearly detected in the perivascular space for the Granta tumors (Fig. 3B) . However, not all vessels in the Granta xenografts seemed permeable for Cy5-Fab-PAS 200 (Supplemental Video 1-5).
Next, non-invasive perfusion experiments using DCE-MRI were performed in CB-17 SCID mice bearing Granta and SUDHL-4 tumor xenografts. The time-dependent concentration curves detected after a bolus injection of the low molecular weight contrast agent Gd-DTPA reveal two major components: first, active perfusion of the tissue based on the arterial input function, which is related to blood flow, and, second, passive diffusion of Gd-DTPA into and out of the extravascular interstitial space, which predominantly depends on vessel permeability and surface area (17) . A matched single slice from a T2-weighted anatomy scan and a Gd-DTPA T1 map obtained prior to and 15 s after Gd-DTPA injection (Fig.   4A ) indicated higher intratumoral Gd-DTPA concentration in Granta compared to SUDHL-4 tumors, in line with the radiotracer distribution experiments. All other organs, including muscles, showed a very similar wash-in pattern independent of the xenograft model. While both tumor models displayed high interindividual differences, the Granta tumors revealed consistently higher wash-in pattern of Gd-DTPA concentration-time curves compared to the SUDHL-4 tumors (Fig. 4B) Fig. 1 ).
Tumor vessel permeability was further analyzed using the fluorescent perfusion dye H33342, which intercalates into cell nuclei adjacent to permeable blood vessels. For simultaneous detection two consecutive cryo-sections of animals treated with the radiolabeled Fab-ABD or Fab-PAS 200 and H33342
were analyzed via autoradiography and immunofluorescence, respectively (Fig. 5A) . A pronounced heterogeneous distribution of H33324 was observed, but no correlation between the distribution of the Fab and the one of H33342 (Fig. 5B) .
Interestingly, comparison of H33342 penetration into the surrounding tumor tissue revealed different patterns: a broad uniform spreading of the perfusion dye was detected in the Granta xenografts, whereas in the SUDHL-4 xenografts merely cells in close proximity to the tumor vessel were stained by H33342 (Fig. 5A) . In order to quantify H33342 tissue penetration, image analysis via distance maps was applied and the H33342 intensity was calculated inside tumor vessels as well as in the surrounding tumor tissue. Almost constant H33342 intensity was detected across the Granta xenografts within a distance of 200 µm from a tumor vessel, whereas SUDHL-4 xenografts revealed a rapid decline in dye intensity with increasing distance from a vessel (Fig. 5C ). by
DISCUSSION
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The distinct behavior of the CD20-positive SUDHL-4 and Granta xenografts with respect to the various tracers investigated here can be explained in part by their differing biomolecular properties. In comparison to the rapidly excreted small imaging compounds 18 F-FDG, Gd-DTPA and H33342 with a molecular size < 1 kDa, both versions of the recombinant CD20 antibody fragment, Fab-ABD and Fab-PAS 200 , exhibit much larger apparent molecular sizes of 40 kDa (≥ 100 kDa after association with albumin) and 219 kDa, respectively, and, consequently, much longer plasma half-lives of 29 and 5 h, while having the same antigen affinity (18) . Low molecular weight compounds usually can rapidly cross the capillary wall, whereas large molecules such as monoclonal antibodies (mAbs) show slower transcapillary and interstitial transport. Therefore, influence of tumor vessel architecture and physiology has a greater impact on macromolecular tracers like antibodies and Fab fragments.
In general, different types of blood vessels are known from the literature. In healthy tissue, a regularly patterned and functional vascularization is found with a normal vessel wall and endothelium.
These semipermeable vessels, with a pore size of 5 nm, allow the efflux of both small molecules and proteins up to around 60 kDa but hinder transcapillary transport of larger proteins, in particular antibodies (19) . For tumors, on the other hand, vessels with a leaky, torturous, dilated and saccular phenotype and a random pattern of interconnections are described, most likely caused by an imbalance of pro-and anti-angiogenic signaling (20, 21) . This perforated phenotype should permit a similar distribution of macromolecular tracers and small molecule reagents outside the tumor vessels. Indeed, in the Granta xenografts we have seen high extravasation for the Fab as well as all three small compounds.
Nevertheless, some vessels did not show this leaky phenotype and were impermeable for the CD20 Fab as observed by LSFM.
Interestingly, the SUDHL-4 xenograft did not match this phenotype, since tumor accumulation of both the Fab-ABD and the small molecules Gd-DTPA and H33342 were clearly reduced. Hence, there seems to occur a second type of distorted tumor vasculature which is characterized by a more closed, by TU Muenchen on November 15, 2016. For personal use only. jnm.snmjournals.org Downloaded from p. 14 Perfusion study of lymphoma xenografts less permeable vasculature. This prevents extravasation of macromolecules and also some small molecules (depending on size, hydrophobicity or charge) whereas low molecular weight metabolites, in particular amino acids and glucose, may still reach the tumor. In fact, such a less permeable vasculature is in accordance with the known low and/or heterogeneous tumor penetration of antibodies and/or drugs previously observed in certain other xenograft models (22) and, even more importantly, in patients (3).
Interstitial hypertension is another factor in tumor physiology that may play a role for tumor targeting and tissue penetration (19, 22) which, in principle, could offer another explanation for the low tracer uptake seen here in the SUDHL-4 xenograft tumors. Indeed, high interstitial fluid pressure (IFP) is assumed to prevent efficient tumor penetration of reagents for imaging and therapy in the biomedical literature (23) . However, while a positive pressure within the tumor tissue would clearly counteract convective molecular transport, it is a misconception that IFP should slow down intratumor molecular diffusion.
IFP is likely caused by local colloid osmotic pressure due to a higher concentration of macromolecules such as polypeptides or proteoglycans in the tumor interstitium. Notably, this phenomenon is somewhat in contradiction with the concept of generally permeable tumor vasculature mentioned above and its consequences for macromolecular accumulation discussed further below. Even in biological systems Newton's law of actio est reactio applies, which means that under circumstances of tissue homeostasis the difference in osmotic pressure between capillary lumen and (tumor) interstitium must equal the static pressure between both compartments. In contrast, diffusion is driven by individual concentration differences -i.e., the chemical potential for each molecular species -which is only marginally affected by static pressure (at least at the moderate values prevailing in a living organism).
Apart from that, there are a couple of other aspects which govern efficient tumor targeting, especially for protein-based tracers or drugs (24) . First, there is the general aspect of vascular by TU Muenchen on November 15, 2016. For personal use only. jnm.snmjournals.org Downloaded from p. 15 Perfusion study of lymphoma xenografts permeability already discussed above. Importantly, most tumors lack lymph drainage, which prevents a convective force that drives permeation of macromolecules through healthy tissues. However, the defective and leaky blood vessels seen in many tumors are considered to cause the so-called enhanced permeability and retention effect. This phenomenon describes the extensive leakage of blood plasma components, in particular large proteins and other macromolecules >40 kDa, into the tumor tissue and their non-specific accumulation there (25) . While the enhanced permeability and retention effect is in fact assumed to promote tumor targeting by antibodies (as well as liposomes, virus-like particles etc.) it does not guarantee proper distribution within the tumor tissue, beyond the capillary vessel.
On the other hand, the most obvious diffusional barrier within the tumor interstitium is the extracellular matrix -especially in the context of a usually crowded tumor parenchyma -which hampers intratumoral distribution of macromolecules in a size-dependent manner (26) . While this aspect deserves more detailed investigation, it has become clear that not only glycosaminoglycans but also various collagens form part of the gel-like structure that causes an interstitial transport resistance. Taken together, the situation is complex, and well-defined model systems are clearly needed. The two distinct xenograft tumors characterized in the present study should prove useful to dissect effects of tumor vessel permeability, extracellular matrix composition and, possibly, IFP in dedicated experimental setups.
In the clinical situation, detection and treatment of tumors with a complex and heterogeneous physiology is difficult, and patients often suffer from inefficient diagnostic or therapeutic efficacy. While, for example, the combination of the CD20-specific antibody Rituximab with standard chemotherapy results in higher overall survival and complete response rates in many subtypes of NHL, a significant proportion of patients relapse with incurable disease (27) . Therefore, assessment of tumor perfusion and permeability in addition to common 18 
